GDRX Q3 2024 Earnings — GoodRx Holdings, Inc. Revenue & Financial Results | Market Cap Arena

GDRXGoodRx Holdings, Inc.

$829M

Q3 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$195M+8.5% YoY

Gross Profit

$184M94.0% margin

Operating Income

$20M10.5% margin

Net Income

$12M6.3% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

-2.7%

Cash Flow

Operating Cash Flow

$87M

Free Cash Flow

$86M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$658M

Stockholders' Equity

$696M

Cash & Equivalents

$424M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$195M	$180M	+8.5%
Gross Profit	$184M	$161M	+13.8%
Operating Income	$20M	-$38M	+153.2%
Net Income	$12M	-$38M	+131.8%

Revenue Segments

Prescription Transactions Revenue

$140M84%

Subscription Revenue

$21M13%

Other Revenue

$5M3%